🔗 Visit the ClinicalTrials.gov page for NCT01267266
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Growth factor and signaling pathways and their relevance to prostate cancer therapeutics. | Cancer Metastasis Rev | 2014 | 0.92 |
| 2 | Emerging molecularly targeted therapies in castration refractory prostate cancer. | Prostate Cancer | 2013 | 0.83 |
| 3 | Use of kinase inhibitors to correct ΔF508-CFTR function. | Mol Cell Proteomics | 2012 | 0.80 |